PDCD1 and laryngeal carcinoma: Additionally, we revealed a high correlation between pRS and PD-L1 expression as well as PD-1 checkpoint pathway, an indication that PD1-related immunotherapy may potentially exert positive benefits on laryngeal cancer patients.